ANTX
AN2 Therapeutics, Inc. Common StockstockNASDAQ
an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.00 | 2026-11-06 | +14.25% | -1.281 |
| 1M | 3.60 | 2026-10-13 | +26.94% | 1.682 |
| 3M | 5.98 | 2026-08-13 | -23.58% | 0.947 |
| 6M | 4.31 | 2026-05-13 | +6.03% | 0.951 |
| 1Y | 1.13 | 2025-11-13 | +304.43% | 0.547 |
| 2Y | 1.01 | 2024-11-13 | +352.48% | — |
| 5Y | 15.40 | 2022-03-25 | -70.33% | 0.800 |
AN2 Therapeutics, Inc. Common Stock (NASDAQ:ANTX) stock price today is $4.57, and today's volume is 205,686. ANTX is up 2.928% today. The 30 day average volume is 298,123. ANTX market cap is $173.40M with 37.94M shares outstanding.
